TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Dala Vård & Vaccin AB
Closing information (x1000 EUR)
Closing information | 2024/04 | 2023/04 | 2022/04 |
Turnover |
1,219
|
1,111
|
722 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
95
|
185
|
28 |
EBITDA |
97
|
192
|
37 |
Total assets |
261
|
303
|
150 |
Current assets |
232
|
269
|
106 |
Current liabilities |
127
|
136
|
110 |
Equity capital |
120
|
157
|
41 |
- share capital |
5
![]() |
5
|
6 |
Employees (average) |
5
![]() |
5
|
4 |
Financial ratios
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Solvency |
46.0%
|
51.8%
|
27.3% |
Turnover per employee |
244
|
222
|
180 |
Profit as a percentage of turnover |
7.8%
|
16.7%
|
3.9% |
Return on assets (ROA) |
36.4%
|
61.1%
|
18.7% |
Current ratio |
182.7%
|
197.8%
|
96.4% |
Return on equity (ROE) |
79.2%
|
117.8%
|
68.3% |
Change turnover |
148
|
454
|
43 |
Change turnover % |
14%
|
69%
|
6% |
Chg. No. of employees |
0
|
1
![]() |
1 |
Chg. No. of employees % |
0%
|
25%
|
33% |
Total value of public sale
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.